pharmacogenomics to personalize drug therapy based on a person's genes

July 2005

See new information from the FDA regarding clearing a genetic lab test for warfarin sensitivity

You'll hear more about using pharmacogenomics to personalize drug therapy based on a person's genes.

Race is sometimes used to predict a person's response to a drug. This is based on the ASSUMPTION that members of a race share genetic similarities.

BiDil (isosorbide and hydralazine), for example, is now the first drug approved for a specific race...treating heart failure in African Americans.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote